Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L R Laufman

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trialC H Spiridonidis, L R Laufman, L Carman, et al.
The Annals of Thoracic Surgery|October 1, 1996
Photodynamic therapy for esophageal malignancy: a prospective twelve-year studyJ S McCaughan, E C Ellison, J T Guy, et al.
Cancer|April 1, 1995
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictorC H Spiridonidis, L R Laufman, K A Stydnicki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trialL R Laufman, C H Spiridonidis, J Pritchard, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
Second-line chemotherapy for non-small-cell lung cancer with monthly docetaxel and weekly gemcitabine: a phase II trialC H Spiridonidis, L R Laufman, L Carman, et al.
The Annals of Thoracic Surgery|October 1, 1996
Photodynamic therapy for esophageal malignancy: a prospective twelve-year studyJ S McCaughan, E C Ellison, J T Guy, et al.
Cancer|April 1, 1995
Decline of posttreatment tumor marker levels after therapy of nonsmall cell lung cancer. A useful outcome predictorC H Spiridonidis, L R Laufman, K A Stydnicki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trialL R Laufman, C H Spiridonidis, J Pritchard, et al.
Pageof 3